Recent studies have also suggested that the increased production of Monocyte Chemoattractant Protein 1 (MCP-1) may be associated with FGF23 metabolism and contribute to CKD progression by promoting monocyte recruitment and their conversion to macrophages in the kidneys [21,22]. Here, FGF23 is linked to chronic kidney disease.